Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

You’re on our free ad-supported tier. Upgrade to NewsNow Essentials for just £4/m now! Your favourite news platform, faster, slicker and ad free.You’re on our free tier. Get NewsNow Essentials at just £4/m now!. Faster, slicker and ad free.You’re on our free tier. Go ad free for just £4/m now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
AI
Business
Football
Sport
Entertainment
Tech
Science

Gilead Sciences
Biotech
Amgen
Topics

Advertisement

Advertisement

Gilead Sciences

Share

Top Latest Popular

NewsNow Essentials. Better browsing, ad free. Just £4/m, billed annually. Upgrade now!

NewsNow Essentials. Your favourite news platform, ad free. £4/m, billed annually. Upgrade now!

Dr Reddy’s inks licensing deal with Gilead for once-yearly HIV lenacapavir The Times of India 6d

The Times of India 6d

Gilead and PAHO announce milestone partnership to accelerate access to HIV pre-exposure treatment PMLiVE 7d

PMLiVE 7d

Gilead launches research facility in US for new medicine development Pharmaceutical Business Review 11:41 Wed, 09 Sep

Pharmaceutical Business Review 11:41 Wed, 09 Sep

Advertisement

Gilead Sciences just won its third FDA approval in less than 4 months. Is the stock still underrating this turnaround play? The Motley Fool 16:10 Sat, 05 Sep

The Motley Fool 16:10 Sat, 05 Sep

Gilead eyes bigger Korea role as country joins 60% of global oncology trials Korea Biomedical Review 1d

Korea Biomedical Review 1d

Advertisement

Advertisement

Latest

Earlier Today

Gilead Sciences (GILD) Stock Moves 1.40%: What You Should Know Zacks 00:03

Yesterday

Notable ETF Inflow Detected - DGRO, PEP, GILD, RTX Nasdaq 16:29 Tue, 22 Sep

Gilead eyes bigger Korea role as country joins 60% of global oncology trials Korea Biomedical Review 08:34 Tue, 22 Sep

Monday

THNR’s Weight-Loss Index Swaps Hims & Hers for Gilead ETF Trends 20:14 Mon, 21 Sep

Equity starts with listening: putting community voices at the centre of access Pharmafile 09:47 Mon, 21 Sep

Thursday

Latin America’s Paho-Gilead HIV Prevention Deal Is a Victory for Civil Society, says Ahf Business Wire (Press Release) 23:37 Thu, 17 Sep

Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know Zacks 15:06 Thu, 17 Sep

Dr Reddy’s inks licensing deal with Gilead for once-yearly HIV lenacapavir The Times of India 14:45 Thu, 17 Sep

Dr Reddy's Inks Pact With Gilead For Once-Yearly HIV Prevention Drug Lenacapavir Outlook Business 09:36 Thu, 17 Sep

Dr Reddy’s expands pact with Gilead for investigational HIV prevention drug The Hindu Business Line 08:41 Thu, 17 Sep

Advertisement

Advertisement

Advertisement

My Local News

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Industry Sectors Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna